Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 1 (January)

1. Simultaneous choroid plexus carcinoma and pilocytic astrocytoma in a pediatric patient.
   J Neurosurg Pediatr, 5(1): 104-12. [Abstract] [Full-text]
2. Rosette-forming glioneuronal tumors of the posterior fossa.
   J Neurosurg Pediatr, 5(1): 98-103. [Abstract] [Full-text]
3. Subarachnoid dissemination of intraventricular tumors following simultaneous endoscopic biopsy and third ventriculostomy.
   J Neurosurg Pediatr, 5(1): 61-7. [Abstract] [Full-text]
4. The transsphenoidal resection of pediatric craniopharyngiomas: a case series.
   J Neurosurg Pediatr, 5(1): 49-60. [Abstract] [Full-text]
5. MAPK pathway activation and the origins of pediatric low-grade astrocytomas.
   J Cell Physiol, 222(3): 509-14. [Abstract] [Full-text]
6. The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.
   Int J Cancer, 126(5): 1155-65. [Abstract] [Full-text]
7. Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma.
   Int J Cancer, 126(5): 1206-15. [Abstract] [Full-text]
8. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.
   Cancer Res, 70(1): 418-27. [Abstract] [Full-text]
9. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.
   Cancer Res, 70(1): 181-91. [Abstract] [Full-text]
10. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.
    Cancer Res, 70(1): 266-76. [Abstract] [Full-text]
11. Brain tumor signs and symptoms: analysis of primary health care records from the UKCCS.
    Pediatrics, 125(1): 112-9. [Abstract] [Full-text]
12. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.
    EMBO J, 29(1): 222-35. [Abstract] [Full-text]
13. Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial.
    J Clin Oncol, 28(2): 305-10. [Abstract] [Full-text]
14. Real-time imaging reveals the single steps of brain metastasis formation.
    Nat Med, 16(1): 116-22. [Abstract] [Full-text]
15. Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation.
    J Clin Endocrinol Metab, 95(1): 13-7. [Abstract] [Full-text]
16. Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma.
    J Clin Endocrinol Metab, 95(1): 289-96. [Abstract] [Full-text]
17. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells.
    J Virol, 84(3): 1563-73. [Abstract] [Full-text]
18. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    Pediatr Blood Cancer, 54(3): 377-83. [Abstract] [Full-text]
19. Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors.
    Pediatr Blood Cancer, 54(3): 429-36. [Abstract] [Full-text]
20. Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma.
    Pediatr Blood Cancer, 54(3): 473-5. [Abstract] [Full-text]
21. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Pediatr Blood Cancer, 54(3): 384-7. [Abstract] [Full-text]
22. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
    Pediatr Blood Cancer, 54(3): 369-76. [Abstract] [Full-text]
23. Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve.
    Strahlenther Onkol, 186(1): 36-9. [Abstract] [Full-text]
24. Derivative (22)t(3;22)(q12;p11.1) in desmoplastic medulloblastoma.
    Cancer Genet Cytogenet, 196(2): 175-8. [Abstract] [Full-text]
25. Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model.
    J Pharmacol Exp Ther, 332(2): 479-88. [Abstract] [Full-text]
26. Protein tyrosine phosphatases in glioma biology.
    Acta Neuropathol, 119(2): 157-75. [Abstract] [Full-text]
27. Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors.
    J Med Chem, 53(2): 876-86. [Abstract] [Full-text]
28. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Acta Radiol, 51(1): 78-84. [Abstract] [Full-text]
29. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.
    Radiology, 254(2): 564-76. [Abstract] [Full-text]
30. Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma.
    Int J Cancer, 126(6): 1436-44. [Abstract] [Full-text]
31. Anaplasia in pilocytic astrocytoma predicts aggressive behavior.
    Am J Surg Pathol, 34(2): 147-60. [Abstract] [Full-text]
32. Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix.
    Carcinogenesis, 31(2): 311-7. [Abstract] [Full-text]
33. DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine.
    Carcinogenesis, 31(2): 184-91. [Abstract] [Full-text]
34. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.
    Cancer Immunol Immunother, 59(4): 541-51. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.